the aid library

LIST OPTIONS

Filter

4920

Sort by:

Direction:

Download (389)

View PDF (273)

Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice
recommended

International Union Against Tuberculosis and Lung Disease (2019) C1

The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens

Download (916)

View PDF (1976)

Technical update on treatment optimization: use of efavirenz during pregnancy: a public health perspective

World Health Organization (2012) C_WHO

1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization

Download (82)

View PDF (156)

Confronting discrimination

UNAIDS (2017) C2

Overcoming HIV-related stigma and discrimination in health- care settings and beyond UNAIDS 2017 | REFERENCE

Download (672)

View PDF (1580)

Malawi Micronutrient Survey Key Indicators Report 2015- 16
recommended

National Statistical Office Zomba, Malawi; Community Health Services Unit, Ministry of Health, Department of Nutrition, HIV and AIDS Lilongwe, Malawi; Centers for Disease Control & Prevention (2017) C1

Download (219)

View PDF (511)

European Union Standards for Tuberculosis Care 2017 Update
recommended

European Centre for Disease Prevention and Control ECDC (2018) CC

The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co... more

Download (81)

View PDF (139)

JPS 2012-2016

UNAIDS (2019) C2

Zero new HIV infections Zero Discrimination Zero AIDS related deaths Accessed: 04.10.2019

Download (113)

View PDF (147)

Thematic report: Stigma and discrimination

T. Noori; A. Pharris European Centre for Disease Prevention and Control (2013) C2

Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 progress Special Report

Download (113)

View PDF (153)

Act 2015 - Advocacy strategy toolkit

UNAIDS; IPPF (International Planned Parenthood Federation); Youth Rise (for reducing drug related harm); et al. (2014) C2

A practical toolkit for young people who are passionate about advancing HIV and sexual and reproductive health and rights through national advocacy in the post-2015 agenda.

Download (309)

View PDF (403)

Le dépistage de l’infection par le virus de l’immunodéficience humaine chez les tuberculeux à Antananarivo, Madagascar

E.J. Rakotonirina, L.A. Raharitiana, L. Ravaoariso, et al. La Revue Médicale de Madagascar (2013) C1

Download (215)

View PDF (321)

Global AIDS Monitoring 2018

Joint United Nations Programme on HIVAIDS (UNAIDS) (2018) C1

Indicators for monitoring the 2016 United Nations Political Declaration on Ending AIDS
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country.... more

Download (382)

View PDF (732)

SAARC Regional Strategy for Control/Elimination of Tuberculosis 2013-2017

SAARC Tuberculosis and HIVAIDS Centre Nepal (2015) C1

The SAARC Member States have more than an estimated 2.0 million TB cases accounting for close to one-third of the total cases of TB in the world. India alone had almost one-fifth of the global disease burden due to TB. India, Pakistan and Bangladesh followed by Afghanistan are the major contributors... more

Download (189)

View PDF (347)

Latent Tuberculosis Infection: A Guide for Primary Health Care Providers

Centers for Disease Control and Prevention, National Center for HIVAIDS, Viral Hepatitis, STD, TB Prevention New Jersey Medical School (2013) C_CDC

Download (98)

View PDF (128)

WHO Information Series on School Health

World Health Organization (WHO); Unicef; Education International ; et al. World Health Organization (WHO); Unicef; Education International ; et al. (2004) C_WHO

Teachers' Exercise Book for HIV Prevention Document 6.1 This booklet contains all the participatory learning experiences that are included in the Training and Resource Manual on School Health and HIV and AIDS Prevention. It is to be given to all teachers who receive training as part of the EI/WH... more

Download (95)

View PDF (110)

HIVi/AIDSi ravi ja hooldus Eestis

D. Raben; S. F. Jakobsen; F. Nakagawa; et al. Maailma Terviseorganisatsioon (Euroopa); WHO Collaborating Centre on HIV and Viral Hepatitis; Centre for Health & Infectious Disease Research (CHIP) (2014) C_WHO

Hindamisaruanne Juuni 2014

Download (135)

View PDF (165)

Abordando estigma e discriminação na resposta à COVID-19

UNAIDS (2020) C_WHO

Applying the evidence of what works from HIV-related stigma and discrimination in six settings to the COVID-19 response This brief provide evidence-informed guidance to countries on the intersection of stigma related to HIV and COVID-19 in national responses.

Download (106)

View PDF (137)

African Union Framework for Antimicrobial Resistance Control 2020–2025
recommended

African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al. (2021) CC

Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency virus (HIV) and the pathogens that cause mala... more

Download (76)

View PDF (411)

Guidelines for the Prevention and Treatment of Opportunistic Infections

Clinical Info HIV gov. (2018) CC

Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The... more

Download (93)

View PDF (89)

Patterns of funding allocation for tuberculosis control in fragile states

Warsame A.; Patel P.; Checchi F. International Journal of Tubercolosis and Lung Disease (2014) CC

The Creditor Reporting System was analysed for official development assistance funding disbursements towards TB control in 11 conflict-affectedstates, 17 non-conflict-affected fragile states and 38 comparable non-fragile states. The amounts of funding, funding relative to burden, funding relative to... more

Download (44)

View PDF (85)

African Union AMR Landmark Report: Voicing African Priorities on the Active Pandemic

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2...020 – 2025, which is tailored to meet the specific needs of African nations through a coordinated approach. While most countries in the region have developed and prioritized National Action Plans (NAPs) to tackle AMR, the overall response remains inadequate given the magnitude of the threat, which endangers human, animal, environmental, aquatic, and plant health. Africa bears a significant burden of infectious diseases, accounting for approximately 95% of malaria deaths, 70% of people living with HIV, and 25% of TB deaths globally. In 2019, AMR was linked to approximately 55,000 deaths from HIV, 30,000 from malaria, and 255,000 overall. Major drivers of AMR in the region include the overuse and misuse of antimicrobials in human and food systems, migration, suboptimal vaccination rates, and environmental contamination from hospital and pharmaceutical effluents. Additionally, there is a lack of access to quality-assured antimicrobials and diagnostics, compounded by inadequate knowledge about AMR. Unlike high-income countries, where indiscriminate antimicrobial use is the primary factor driving AMR, African countries face additional challenges, including a lack of access to clean and safe water, poor Water, Sanitation, and Hygiene (WASH) programs, inadequate infection prevention measures, and suboptimal vaccinations for preventable diseases. One in three hospitals in the region lacks clean, safe running water, and one in eight people defecate openly due to inadequate sanitation. Investments in WASH, infection prevention, and biosecurity could save approximately 700,000 lives annually. Addressing AMR in Africa requires a comprehensive, multi-sectoral approach involving the entire society. Sustainable access to antimicrobials, including antibiotics, vaccines, and therapeutics, is crucial, as lack of access leads to more morbidity and mortality than AMR itself. Support for the region should focus on preventing infections, strengthening health and food systems, developing human resources, ensuring sustainable access to diagnostics and therapeutics, and investing in laboratory infrastructure to support surveillance and data generation. more

Download (7)

View PDF (6)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice recommended

Malawi Micronutrient Survey Key Indicators Report 2015- 16 recommended

European Union Standards for Tuberculosis Care 2017 Update recommended

African Union Framework for Antimicrobial Resistance Control 2020–2025 recommended

Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice
recommended

Malawi Micronutrient Survey Key Indicators Report 2015- 16
recommended

European Union Standards for Tuberculosis Care 2017 Update
recommended

African Union Framework for Antimicrobial Resistance Control 2020–2025
recommended